Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III
about
Lipoprotein genotype and conserved pathway for exceptional longevity in humansApolipoprotein C3 SstI polymorphism and triglyceride levels in Asian IndiansMitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4A broad role for the zinc finger protein ZNF202 in human lipid metabolismTranscriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalphaGPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphismsRegulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acidAntagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cellsAssociations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemiaThe roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolismNew Era of Lipid-Lowering DrugsANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipaseThe genetics of serum lipid responsiveness to dietary interventions.Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from Schistosoma mansoni-infected individualsLiver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levelsIdentification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes.Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levelsOrphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter.Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibratesAPOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family.Mapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles.Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout miceVertical sleeve gastrectomy restores glucose homeostasis in apolipoprotein A-IV KO mice.PPAR-alpha effects on the heart and other vascular tissues.Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotypeApolipoprotein A1/C3/A5 haplotypes and serum lipid levelsThe contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variabilityLowering triglycerides to modify cardiovascular risk: will icosapent deliver?Maternal inheritance of severe hypertriglyceridemia impairs glucose metabolism in offspring.Isotretinoin and FoxO1: A scientific hypothesis.Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysisThe Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma TriglyceridesApolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.Tryptophan probes reveal residue-specific phospholipid interactions of apolipoprotein C-IIIDose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia.
P2860
223c10cb5c268544a8dd235b64ad6407a32ad46350bf38cecf2a98bf9b3cb3983b783b6ef1802b3f6963a992886309861a1bf5a8decefa25682939c6ac33c8aa940c4cdec2b7eb34b906ebe7d8de0303b1beebac60fa9287e5714597e6acfebb9d9c32d5e531af3fc6c1e6ef454732c3b055c88a76a3475dede39d74e1bc28ba558b4395ae7223837690f9bdf5274bef7bf8168cbf06bc9f08de77ef8fa66b48
P248
Q21146060-6DEFECDF-5DBF-43DE-91EF-172E6056B3FDQ21283798-9B9D510F-8A52-4A23-82F6-9990B4542EB9Q22010768-237E5034-B69D-46C3-8282-D6D888F6B43FQ22253447-889BB30E-6F7B-4FA0-881F-CF6BC174547BQ24290442-60AA836E-BD18-4B66-8BDB-189F98F29BB4Q24338849-3CE58F24-527C-4864-9138-66FAFF56631BQ24562942-B8FDB4C9-94D0-4A6A-884B-BC85C1C97152Q24594113-939AADBF-ADB0-4E42-9573-237DDF56AA46Q24606324-C8F61BD6-63E6-4C31-9A9B-94638C16B631Q25255216-93DA7D36-3BB8-46D0-AB1A-C9D64CAA442FQ26864682-9C547891-A537-442E-86E9-6B2C789FBE1BQ27021950-2A503254-A122-4791-86E1-F37C70C0B1BBQ28072298-B54F28B1-57E9-49D4-8829-440ED1D506FEQ28505778-5985389A-A87E-48DC-8CC9-B4F2CFEDE1E3Q28572175-C477397C-29DB-421C-AC8A-BBAE6A0A7556Q33644526-0D0A113A-7D0E-439C-9A3D-D80CB057E1E9Q33812839-27296309-D785-4E7A-B62A-E162AA05D428Q33958622-2B4807D6-8DFA-45D3-846A-89376E08A3C6Q34078908-2EFDA56C-53F0-45C3-8980-FBABB846BF94Q34088158-9FE97F0F-7839-4C6B-8FAF-94CC3BDC595FQ34129395-755F3607-7B15-446E-BCC1-91C6355F2126Q34188082-11D68399-987D-4636-9B50-E60ACA20764CQ34201490-92B3DFE2-1C35-405F-8F39-A7F4746AB46CQ34476810-A2C4CA01-FD4B-4660-A734-DB17B499380EQ34555445-32A82AD0-91B7-4B9C-BA20-C890346EFE6FQ34570994-23349C45-5FFA-4830-BD39-DEAFF4B807CDQ34946523-AA1196F2-03A0-4939-96D8-9D90DAE0DBA2Q35004370-8132A06A-ED39-44C2-9EC4-DD2435EC7A9BQ35080447-4A5456AC-9357-4C63-8917-F3ECC7F8DF9FQ35157797-34B63297-3717-4BD6-A541-312F2D337825Q35206176-D884F3D7-BDE8-4B4D-B94D-4248E57F4786Q35222189-6FFAB401-6F60-4955-A672-E220ABD6586AQ35230819-507AAA52-8A22-4400-8DAB-B422B1EDB0FDQ35310272-2B915469-B8B1-40B6-96F2-986A11D17BF1Q35558873-1B147548-855F-45BE-9C5A-3BA8C3CE271DQ35687045-95D85920-3D01-41BB-8067-1FDF286A623FQ35860314-6B4D38A6-E0CF-4ACE-BB50-88515F8DCCE2Q35915137-57925BF1-3D61-43E0-9556-8ED60A143EB1Q36137606-98204844-061E-487D-BADF-A6B24E0351D8Q36368459-F3FD2957-1A03-455B-9408-906EC0CEED6D
P2860
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III
description
1985 nî lūn-bûn
@nan
1985 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@ast
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@en
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@en-gb
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@nl
type
label
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@ast
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@en
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@en-gb
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@nl
prefLabel
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@ast
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@en
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@en-gb
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@nl
P2093
P2860
P921
P356
P1476
Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III
@en
P2093
P Alaupovic
W J McConathy
P2860
P304
P356
10.1172/JCI111711
P407
P577
1985-02-01T00:00:00Z